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Muneretto and colleagues1 demonstrated excellent results inpatients having total arterial compared with conventionalarterial and venous grafting for coronary artery disease in aprospective randomized study. Free arterial grafts are beingused increasingly to replace the saphenous vein as a conduitto avoid the late complications of vein graft atherosclerosis.
The aim is to prevent major ischemic complications and reoperation. To date,
increased complexity, safety, and efficacy concerns have limited the acceptance of
extensive or complete arterial grafting. Symptom-directed angiography and late
clinical follow-up suggest that the benefits of arterial versus venous grafting have
become more obvious with time. Well-constructed and well-conducted prospective
randomized controlled trials are therefore very important to define the benefits, if
any, and which patients should receive only arterial grafts.
These authors have included a wide range of patients but excluded those with
diabetes, obesity, lung disease, and steroids, in whom the risks of sternal ischemia
and infection are considered to be high. The information from randomized clinical
trials should not be applied universally but rather be confined to similar subsets of
patients. In the series by Muneretto and colleagues,1 there were few patient exclu-
sions, and therefore these results are relevant to most clinical practices. Semiskel-
etonization of the internal thoracic artery (ITA) and avoidance of the pleura will
minimize chest wall trauma and preserve lung function, thereby increasing the
application of the ITA to higher-risk patients. Vein harvesting is often left to junior
staff, which might have contributed to the high early failure rate of saphenous vein
grafts at 12 months (15%). The use of a high concentration of papaverine (5
mmol/L) for preparation of radial and right ITAs but not saphenous veins might also
have introduced bias.2
The authors’ algorithm for complete arterial grafting is complex. Their arterial
grafting strategy depends primarily on a single arterial inflow through the left ITA
by using a radial artery Y graft in 54% of patients, thus avoiding right ITA
harvesting and aortic manipulation. A dual inflow with a radial artery and left ITA
system was used in those patients with a dominant right system (38%). Where there
is doubt about the ability of a Y graft to adequately revascularize the distal branches,
a second Y graft is fashioned with the distal left ITA. The patency of sequential
grafts in the presence of a normal inflow will depend on the level of competitive
flow in each of the target arteries. Poor patency results have been reported with a
radial artery sequential graft to the right coronary artery with a low-grade stenosis.3
Many surgeons are reluctant to use a free arterial graft to a native vessel with a
stenosis of less than 70% because of a 3-fold increased risk of graft failure.4
Myocardial hypoperfusion remains a theoretical and practical complication when
using arterial grafts. Avoidance of hypotension and a low cardiac output in the
perioperative period are essential. Graft spasm might be reduced by the use of
disease-free arterial conduits, meticulous surgical techniques, topical and (to a lesser
extent) systemic vasodilatation with calcium-channel blockade, nitric oxide–cyclic
guanosine monophosphate pathway enhancement, and  receptor blockade.5 Al-
though there is an adequate flow reserve in a normal left ITA, dependence on a
single arterial inflow might pose short-term and long-term ischemic problems if
there is proximal disease either in the subclavian artery or ITA or at the level of the
Y anastomosis.
Postoperative angiography was performed in 70% of the patients in the study by
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Muneretto and colleagues.1 The exact numbers of the var-
ious grafts were not specified. The authors report a 100%
patency (n  140) of the left ITA to the graft of the left
anterior descending artery and a 1.4% (1/72) failure rate for
the radial artery. A string sign developed in 7.5% (3/40) of
right ITAs, and there was an 11% (15/137) failure rate for
the saphenous vein. Most surgeons would regard the string
sign as graft failure, thus increasing the total non–left ante-
rior descending arterial graft failure rate to 3.6%. The dif-
ference in patency between the arterial venous saphenous
grafts remains significant (P  .04). Although the clinical
results parallel those of the graft patency, critical analysis of
the quality of the end points is essential. Cardiac event–free
survival is only useful if the various events are robust.
Recurrence of angina is a very weak end point, and nonfatal
myocardial infarction requires careful definition. Graft oc-
clusion, reintervention, and death are strong end points on
which the trial outcome analyses should depend. The num-
bers of events that make up the composite end point are not
documented. A more meaningful clinical analysis should
exclude angina, which would improve the credibility of
results but reduce the power of the statistics.
The criteria for accepting the radial artery as a conduit
are important. Inadequate ulnar collateral circulation occurs
in about 5% of patients, preventing the use of the radial
artery. Disease in the radial artery is more common than in
the ITA.6 In elderly patients undergoing coronary artery
bypass surgery, adaptive fibrointimal hyperplasia, calcifica-
tion, and atheroma are common pathologic findings in radial
arteries. Until the effect of these disease processes on graft
function is defined, the use of radial arteries or ITAs with
macroscopic disease is probably best avoided.
The findings of Muneretto and colleagues1 are important
and should be viewed in the context of the Radial Artery
Patency Study7 and the Radial Artery Patency and Clinical
Outcomes 5-year interim results.8 The Radial Artery Pa-
tency and Clinical Outcomes study confirms that right ITA
and radial artery grafts in the non–left anterior descending
artery position can be used safely; however, no benefits
were detected at 5 years. The Radial Artery Patency Study
compares the patency of the saphenous vein with that of the
radial artery. A total of 526 patients have been entered in
this study, and the early angiographic results will be re-
ported shortly.6 The longitudinal follow-up of patients over
the next 10 years from these 3 studies will provide surgeons
with valuable information about the patency of arterial
compared with saphenous vein grafts and the clinical out-
comes. Until that time, the hypothesis that total arterial
grafting is superior to conventional arterial and venous
grafting remains unproven.
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